These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Pachychoroid neovasculopathy: a type-1 choroidal neovascularization belonging to the pachychoroid spectrum-pathogenesis, imaging and available treatment options. Sartini F; Figus M; Casini G; Nardi M; Posarelli C Int Ophthalmol; 2020 Dec; 40(12):3577-3589. PubMed ID: 32729062 [TBL] [Abstract][Full Text] [Related]
11. Vortex Vein Anastomosis at the Watershed in Pachychoroid Spectrum Diseases. Matsumoto H; Hoshino J; Mukai R; Nakamura K; Kikuchi Y; Kishi S; Akiyama H Ophthalmol Retina; 2020 Sep; 4(9):938-945. PubMed ID: 32651158 [TBL] [Abstract][Full Text] [Related]
12. Choroidal vascular densities of macular disease on ultra-widefield indocyanine green angiography. Lee A; Ra H; Baek J Graefes Arch Clin Exp Ophthalmol; 2020 Sep; 258(9):1921-1929. PubMed ID: 32494872 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Regional Differences in the Choroidal Thickness between Patients with Pachychoroid Neovasculopathy and Classic Exudative Age-related Macular Degeneration. Kim YH; Lee B; Kang E; Oh J Curr Eye Res; 2021 Sep; 46(9):1398-1405. PubMed ID: 33550884 [No Abstract] [Full Text] [Related]
14. Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration. Matsumoto H; Hiroe T; Morimoto M; Mimura K; Ito A; Akiyama H Jpn J Ophthalmol; 2018 Mar; 62(2):144-150. PubMed ID: 29411171 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of type 1 neovascularization: Neovascular age-related macular degeneration versus pachychoroid neovasculopathy. Altinisik M; Kurt E; Sonmezer P; Kayikcioglu O; Ilker SS Eur J Ophthalmol; 2022 Jul; 32(4):2404-2411. PubMed ID: 34374308 [TBL] [Abstract][Full Text] [Related]
16. The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy. Azuma K; Tan X; Asano S; Shimizu K; Ogawa A; Inoue T; Murata H; Asaoka R; Obata R PLoS One; 2019; 14(2):e0212055. PubMed ID: 30763369 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and Risk Factors for Nonexudative Neovascularization in Fellow Eyes of Patients With Unilateral Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy. Yanagi Y; Mohla A; Lee WK; Lee SY; Mathur R; Chan CM; Yeo I; Wong TY; Cheung CMG Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3488-3495. PubMed ID: 28702676 [TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography angiography characteristics of exudative and non-exudative treatment-naïve pachychoroid neovasculopathy. Yang C; Sun ZH; Zhou TY; Zheng WW; Liu XL; Lin B Int J Ophthalmol; 2023; 16(12):2027-2033. PubMed ID: 38111944 [TBL] [Abstract][Full Text] [Related]
19. Changes in Choroidal Thickness After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy. Padrón-Pérez N; Arias L; Rubio M; Lorenzo D; García-Bru P; Català-Mora J; Caminal JM Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1119-1124. PubMed ID: 29490349 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Morphological Features of Type 1 CNV in AMD and Pachychoroid Neovasculopathy: An OCTA Study. Biçer Ö; Demirel S; Yavuz Z; Batioğlu F; Özmert E Ophthalmic Surg Lasers Imaging Retina; 2020 Nov; 51(11):640-647. PubMed ID: 33231697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]